S

Srinivasan

Active Director Director DIN 02391142
DIN 02391142 First appointment Mar 1998 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Mar 1998
Shareholding value •••• Premium profile

About Srinivasan

Data last updated:

Srinivasan is a Director at Pride Super Speciality Hospital Private Limited (since 2019) and Director at Novacure Research Labs Private Limited (since 2019). The companies operate in Healthcare, FMCG and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹14.75 Cr; the largest is Pride Super Speciality Hospital Private Limited at ₹14.75 Cr (FY 2024). Earlier, Srinivasan was a Managing Director at Muthu Pharmacy Private Limited (2007–2019) and Director at Muthu Pharma Private Limited (2016) and 3 more.

DIN 02391142
Primary Designation Director
Industry Healthcare
First Appointment 13 Mar 1998
Oldest Company Age 16 yrs
Largest company Pride Super Speciality Hospital Private Limited · ₹14.75 Cr (FY 2024)
Combined revenue ₹14.75 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20192010₹14.75 Cr (FY 2024)Active
Director27 Aug 20192019₹8,000 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Muthu Pharmacy Private Limited U24230TN2007PTC063047
Managing Director09 Apr 20072007₹52.25 Cr (FY 2024)Active
Muthu Pharma Private Limited U51909MH2016PTC449216
Director11 Mar 20162016₹235 Cr (FY 2022)Active
Pearl Medicals Private Limited U85120MH1999PTC449218
Managing Director14 Jul 19991999₹46.69 Cr (FY 2022)Active
Director13 Mar 19981998₹94.1 Lakh (FY 2024)Active
Director05 Aug 20092009₹16.43 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Novacure Research Labs Private Limited
Pride Super Speciality Hospital Private Limited
Muthu Pharmacy Private Limited
Muthu Pharma Private Limited
Premium access

Shareholding and investment profile for Srinivasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasan

Srinivasan currently holds 2 directorships: Pride Super Speciality Hospital Private Limited (Director, since 01 Jul 2019, revenue ₹14.75 Cr (FY 2024)); Novacure Research Labs Private Limited (Director, since 27 Aug 2019, revenue ₹8,000 (FY 2025)).

Srinivasan was first appointed on 13 Mar 1998 as Director at Muthu Pharma Agencies Private Limited. The most recent appointment on record is 27 Aug 2019 at Novacure Research Labs Private Limited.

The 2 current companies of Srinivasan that report revenue have a combined latest revenue of ₹14.75 Cr: Pride Super Speciality Hospital Private Limited ₹14.75 Cr (FY 2024); Novacure Research Labs Private Limited ₹8,000 (FY 2025).

Srinivasan held 5 earlier board appointments: Muthu Pharmacy Private Limited (Managing Director, 09 Apr 2007 to 30 Jun 2019); Muthu Pharma Private Limited (Director, 11 Mar 2016 to 14 Oct 2016); Pearl Medicals Private Limited (Managing Director, 14 Jul 1999 to 14 Oct 2016); Muthu Pharma Agencies Private Limited (Director, 13 Mar 1998 to 21 Feb 2017); Shell Pharmaceuticals Private Limited (Director, 05 Aug 2009 to 03 Nov 2017).

The current boards of Srinivasan's companies include Srinivasan Chokalingam (Pride Super Speciality Hospital Private Limited), Srinivasan Muthu (Novacure Research Labs Private Limited), Srinivasan Visalakshi (Novacure Research Labs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available